Literature DB >> 8231788

Bloom syndrome: a mendelian prototype of somatic mutational disease.

J German1.   

Abstract

Spontaneous mutations in human somatic cells occur far more often than normal in individuals with Bloom syndrome. The basis for understanding these mutations and their developmental consequences emerges from examination of BS at the molecular, cellular, and clinical levels. The major clinical feature of BS, proportional dwarfism, as well as its major clinical complication, an exceptionally early emergence of neoplasia of the types and sites that affect the general population, are attributable to the excessive occurrence of mutations in somatic cells. Here, the following aspects of BS are discussed: (i) the BS phenotype; (ii) neoplasia in BS, including the means--the Bloom's Syndrome Registry--by which the significant risk for diverse sites and types of cancer in these patients was revealed; (iii) the biological basis for the cancer proneness of BS; and, finally, (iv) the significance for both basic human biology and clinical medicine of BS as the prototype of somatic mutational disease.

Entities:  

Mesh:

Year:  1993        PMID: 8231788

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  169 in total

1.  Transfection of BLM into cultured bloom syndrome cells reduces the sister-chromatid exchange rate toward normal.

Authors:  N A Ellis; M Proytcheva; M M Sanz; T Z Ye; J German
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

2.  Werner's syndrome protein (WRN) migrates Holliday junctions and co-localizes with RPA upon replication arrest.

Authors:  A Constantinou; M Tarsounas; J K Karow; R M Brosh; V A Bohr; I D Hickson; S C West
Journal:  EMBO Rep       Date:  2000-07       Impact factor: 8.807

3.  The Bloom's syndrome gene product promotes branch migration of holliday junctions.

Authors:  J K Karow; A Constantinou; J L Li; S C West; I D Hickson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 4.  Immunodeficiency associated with DNA repair defects.

Authors:  A R Gennery; A J Cant; P A Jeggo
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

5.  Potent inhibition of werner and bloom helicases by DNA minor groove binding drugs.

Authors:  R M Brosh; J K Karow; E J White; N D Shaw; I D Hickson; V A Bohr
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

6.  Cleavage of the Bloom's syndrome gene product during apoptosis by caspase-3 results in an impaired interaction with topoisomerase IIIalpha.

Authors:  R Freire; F d'Adda Di Fagagna; L Wu; G Pedrazzi; I Stagljar; I D Hickson; S P Jackson
Journal:  Nucleic Acids Res       Date:  2001-08-01       Impact factor: 16.971

7.  The Bloom's and Werner's syndrome proteins are DNA structure-specific helicases.

Authors:  P Mohaghegh; J K Karow; R M Brosh; V A Bohr; I D Hickson
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

8.  Direct association of Bloom's syndrome gene product with the human mismatch repair protein MLH1.

Authors:  G Pedrazzi; C Perrera; H Blaser; P Kuster; G Marra; S L Davies; G H Ryu; R Freire; I D Hickson; J Jiricny; I Stagljar
Journal:  Nucleic Acids Res       Date:  2001-11-01       Impact factor: 16.971

9.  The Bloom's syndrome helicase stimulates the activity of human topoisomerase IIIalpha.

Authors:  Leonard Wu; Ian D Hickson
Journal:  Nucleic Acids Res       Date:  2002-11-15       Impact factor: 16.971

10.  Sgs1 helicase activity is required for mitotic but apparently not for meiotic functions.

Authors:  A Miyajima; M Seki; F Onoda; M Shiratori; N Odagiri; K Ohta; Y Kikuchi; Y Ohno; T Enomoto
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.